Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Rhodococcus sp. (MG1) induced biochemical alterations and genotoxicity in Spodoptera litura.

Scientific reports·2026
Same author

Sesamol as a multifunctional antioxidant in tissue injury and repair: mechanistic insights and therapeutic perspectives.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Drugs detected in suspected pediatric exposures: a 5-year review.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Transient Infantile Liver Failure due to TRMU Deficiency: The Role of Rapid Exome Sequencing.

Indian journal of pediatrics·2026
Same author

Towards smarter pacemakers: robot-shaped antenna for efficient wireless telemetry in leadless cardiac implants.

Biomedical materials (Bristol, England)·2026
Same author

A Fatal Case of Coronary Thrombosis in a Young Male Triggered by Marijuana Use.

Cureus·2025
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.2K

Evaluating Novel Markers for Specimen Validity Testing.

Patrick B Kyle1, Jaswinder Kaur1

  • 1From the Department of Pathology, University of Mississippi Medical Center, Jackson.

Archives of Pathology & Laboratory Medicine
|November 23, 2019
PubMed
Summary
This summary is machine-generated.

Synthetic urine products can evade drug screens, necessitating new validity tests. A new LC-MS/MS assay effectively identified these synthetic samples, improving drug testing accuracy.

More Related Videos

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers
08:44

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers

Published on: June 11, 2018

10.9K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K

Related Experiment Videos

Last Updated: Jan 3, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.2K
Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers
08:44

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers

Published on: June 11, 2018

10.9K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K

Area of Science:

  • Forensic Toxicology
  • Analytical Chemistry
  • Clinical Chemistry

Background:

  • Synthetic urine is widely used to falsify drug tests, posing a challenge to accurate screening.
  • Current specimen validity tests are insufficient to detect these artificial samples.
  • Novel markers are needed to identify synthetic urine specimens effectively.

Purpose of the Study:

  • To develop and validate a multicomponent liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for urine specimen validity testing.
  • To assess the effectiveness of the assay in detecting synthetic urine products.
  • To identify new markers for improved urine specimen validity.

Main Methods:

  • A quantitative LC-MS/MS assay was developed to measure caffeine, cotinine, theobromine, and urobilin in urine.
  • The assay was tested on synthetic urine samples and human specimens from various testing contexts.
  • Failed specimens underwent further analysis including urinalysis and comprehensive GC-MS.

Main Results:

  • The LC-MS/MS assay successfully identified 100% of synthetic urine products tested.
  • The assay also detected nonphysiologic specimens in pre-employment (2.4%) and pain management (2.0%) testing.
  • Follow-up analyses confirmed the nonphysiologic nature of the failed specimens.

Conclusions:

  • The developed 4-marker LC-MS/MS assay is a robust method for detecting nonphysiologic urine specimens.
  • The findings highlight the inadequacy of current validity criteria against synthetic urine.
  • Development of new validity markers is crucial for detecting commercially available synthetic urine products.